KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Inventory Average (2016 - 2026)

Gilead Sciences filings provide 17 years of Inventory Average readings, the most recent being $1.8 billion for Q4 2025.

  • On a quarterly basis, Inventory Average fell 0.56% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a 0.56% decrease, with the full-year FY2025 number at $1.7 billion, changed 0.37% from a year prior.
  • Inventory Average hit $1.8 billion in Q4 2025 for Gilead Sciences, down from $1.8 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $1.9 billion in Q3 2024 to a low of $1.5 billion in Q3 2022.
  • Median Inventory Average over the past 5 years was $1.7 billion (2021), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Inventory Average: skyrocketed 81.45% in 2021 and later fell 16.19% in 2022.
  • Gilead Sciences' Inventory Average stood at $1.6 billion in 2021, then decreased by 9.84% to $1.5 billion in 2022, then grew by 16.16% to $1.7 billion in 2023, then rose by 3.74% to $1.8 billion in 2024, then decreased by 0.56% to $1.8 billion in 2025.
  • The last three reported values for Inventory Average were $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.8 billion (Q2 2025) per Business Quant data.